OIS Podcast Ep скачать в хорошем качестве

OIS Podcast Ep

In this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment. Tarsier’s lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care. In this episode, you’ll learn: 🔹 How Tarsier’s bio-inspired molecule is changing the game in ophthalmology. 🔹 Why steroids, despite being the standard of care, can be problematic for uveitis patients. 🔹 The challenges of scaling manufacturing and securing regulatory approval for novel ophthalmic treatments. 🔹 Insights from Ashley Kline on the commercial strategy for launching Tarsier’s therapy. 🔹 How Dr. Rothman sees this innovation reshaping ophthalmology and glaucoma treatment. 🎧 Tune in to hear how Tarsier Pharma is working to bring a safer, more effective treatment to market! Subscribe to the OIS Podcast today! Website: https://ois.net FOLLOW Ophthalmology Innovation Source On Social Media: ► LinkedIn:   / ois-net   ► Twitter:   / oistweets   JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn   / 2189664   SUBSCRIBE To Our Weekly OIS Newsletter http://bit.ly/2yFOXUt VIEW Our Past Ophthalmology Event Conferences: https://ois.net/past-events REGISTER For Our Next Meeting: https://ois.net/ois-events/ #OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases _________________________________________________________________ About OIS Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs. Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.